Literature DB >> 16712824

Determination of adiponectin in serum using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer.

Ayako Nishimura1, Tokio Sawai.   

Abstract

BACKGROUND: Adiponectin is an adipose-derived hormone that plays a role in regulating metabolic processes such as fat partitioning and lipid and glucose metabolism. Quantification of adiponectin is useful for obtaining information on metabolic syndrome, but there is no rapid method to measure adiponectin for clinical use.
METHODS: We developed a rapid and sensitive latex particle-enhanced turbidimetric immunoassay (LTIA) using a latex bead-immobilized anti-adiponectin polyclonal antibody. The assay was performed on a Hitachi H7170 analyzer and evaluated for validity as a method to quantitate adiponectin, in parallel with the ELISA.
RESULTS: Dilution tests using LTIA showed linearity from 0.25 to 30 microg/ml. Within-run CV and total CV were obtained in the range of 0.8-1.9% and 1.1-2.0%, respectively. No interference was observed in the testing of specimens containing potentially interfering substances such as bilirubin, ditaurobilirubin, hemoglobin triglyceride, rheumatoid factor, type IV collagen, fibronectin, and complement factor (C1q). A strong correlation between LTIA and ELISA was confirmed (n=30, r=0.990, y=0.95x+0.39).
CONCLUSION: The LTIA assay is applicable to quantitating the serum concentration of adiponectin. This assay is more convenient and faster than ELISA and suitable for clinical routine analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16712824     DOI: 10.1016/j.cca.2006.03.008

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  30 in total

Review 1.  Metabolic syndrome and lifestyle modification.

Authors:  Mitsuyoshi Takahara; Iichiro Shimomura
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

2.  Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.

Authors:  Thomas M van Himbergen; Alexa S Beiser; Masumi Ai; Sudha Seshadri; Seiko Otokozawa; Rhoda Au; Nuntakorn Thongtang; Philip A Wolf; Ernst J Schaefer
Journal:  Arch Neurol       Date:  2012-05

3.  Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study.

Authors:  Masumi Ai; Seiko Otokozawa; Bela F Asztalos; Charles C White; L Adrienne Cupples; Katsuyuki Nakajima; Stefania Lamon-Fava; Peter W Wilson; Yuji Matsuzawa; Ernst J Schaefer
Journal:  Atherosclerosis       Date:  2011-06-12       Impact factor: 5.162

4.  Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patients.

Authors:  Yoshiya Hosokawa; Yuya Yamada; Yoshinari Obata; Megu Yamaguchi Baden; Kenji Saisho; Arisa Ihara; Koji Yamamoto; Kiyonori Katsuragi; Yuji Matsuzawa
Journal:  Clin Exp Nephrol       Date:  2011-11-30       Impact factor: 2.801

5.  Validation of 2 commercially available enzyme-linked immunosorbent assays for adiponectin determination in canine serum samples.

Authors:  Asta Tvarijonaviciute; Silvia Martínez-Subiela; José J Ceron
Journal:  Can J Vet Res       Date:  2010-10       Impact factor: 1.310

6.  Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.

Authors:  Nuntakorn Thongtang; Masumi Ai; Seiko Otokozawa; Thomas V Himbergen; Bela F Asztalos; Katsuyuki Nakajima; Evan Stein; Peter H Jones; Ernst J Schaefer
Journal:  Am J Cardiol       Date:  2011-02-01       Impact factor: 2.778

7.  Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry.

Authors:  Yuji Komorita; Masanori Iwase; Hiroki Fujii; Toshiaki Ohkuma; Hitoshi Ide; Tamaki Jodai-Kitamura; Akiko Sumi; Masahito Yoshinari; Udai Nakamura; Dongchon Kang; Takanari Kitazono
Journal:  Diabetologia       Date:  2017-07-18       Impact factor: 10.122

8.  Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.

Authors:  Stefania Lamon-Fava; Margaret R Diffenderfer; P Hugh R Barrett; Aaron Buchsbaum; Mawuli Nyaku; Katalin V Horvath; Bela F Asztalos; Seiko Otokozawa; Masumi Ai; Nirupa R Matthan; Alice H Lichtenstein; Gregory G Dolnikowski; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

9.  Substitution of vegetable oil for a partially-hydrogenated fat favorably alters cardiovascular disease risk factors in moderately hypercholesterolemic postmenopausal women.

Authors:  Sonia Vega-López; Nirupa R Matthan; Lynne M Ausman; Masumi Ai; Seiko Otokozawa; Ernst J Schaefer; Alice H Lichtenstein
Journal:  Atherosclerosis       Date:  2009-04-05       Impact factor: 5.162

10.  Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.

Authors:  Kieren J Mather; Tohru Funahashi; Yuji Matsuzawa; Sharon Edelstein; George A Bray; Steven E Kahn; Jill Crandall; Santica Marcovina; Barry Goldstein; Ronald Goldberg
Journal:  Diabetes       Date:  2008-01-11       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.